{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T16:25:35Z","timestamp":1794932735751,"version":"4.9.1"},"reference-count":70,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Merck Sharp & Dohme LLC"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Vaccines"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/14760584.2026.2678266","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T07:30:53Z","timestamp":1779435053000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Epidemiological impact of a 20- or 21-valent pneumococcal conjugate vaccine in the Japan adult population: insights from a dynamic transmission model"],"prefix":"10.1080","volume":"25","author":[{"given":"Rachel J.","family":"Oidtman","sequence":"first","affiliation":[{"name":"Merck & Co., Inc","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Tajima","sequence":"additional","affiliation":[{"name":"MSD K.K","place":["Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taizo","family":"Matsuki","sequence":"additional","affiliation":[{"name":"MSD K.K","place":["Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter P.","family":"Mueller","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tufail","family":"Malik","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin M.","family":"Bakker","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Burgess","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Lang","sequence":"additional","affiliation":[{"name":"Merck Canada, Inc","place":["Kirkland, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwaseun","family":"Sharomi","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"key":"e_1_3_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(22)00303-2"},{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-024-01116-z"},{"key":"e_1_3_7_4_1","volume-title":"Minutes of the 61st meeting of the vaccination and vaccine subcommittee, basic policy on vaccinations, health sciences council","author":"Ministry of Health, Labor and Welfare","year":"2024","unstructured":"Ministry of Health, Labor and Welfare. Minutes of the 61st meeting of the vaccination and vaccine subcommittee, basic policy on vaccinations, health sciences council. Ministry of Health LaW; 2024. https:\/\/www.mhlw.go.jp\/content\/10900000\/001276351.pdf"},{"key":"e_1_3_7_5_1","unstructured":"Pharmaceuticals and Medical Devices Agency. Label for pneumococcal 15-valent conjugate vaccine. 2023 [cited 2023 Aug 1]. Available from: https:\/\/www.pmda.go.jp\/PmdaSearch\/iyakuDetail\/GeneralList\/631140K"},{"key":"e_1_3_7_6_1","unstructured":"Japan Pediatric Society\u2019s Committee on Immunization and Infectious Diseases. Approach to routine pneumococcal conjugate vaccination in children. 2024 [cited 2025 Jan]. Available from: https:\/\/www.jpeds.or.jp\/uploads\/files\/20241029_haienq.pdf"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2025.127138"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid2007.131485"},{"key":"e_1_3_7_9_1","unstructured":"E-Stat. Regional health and health promotion project report. [cited 2023 Aug 1]. Available from: https:\/\/www.e-stat.go.jp\/stat-search\/files?page=1&query=%E4%BA%88%E9%98%B2%E6%8E%A5%E7%A8%AE&toukei=00450025&tstat=000001030884&metadata=1&data=1"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.07.069"},{"key":"e_1_3_7_11_1","unstructured":"Ministry of Health Labor and Welfare. Minutes of the 24th meeting of the vaccination and vaccine subcommittee basic policy on vaccinations the central social insurance medical council. 2018 [cited 2025 Aug]. Available from: https:\/\/www.mhlw.go.jp\/stf\/shingi2\/0000210542_00002.html"},{"issue":"1","key":"e_1_3_7_12_1","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1080\/13696998.2024.2445429","article-title":"Health and economic impact of the 21-valent pneumococcal conjugat vaccine (V116) for adults in Japan: A delta price approach","volume":"28","author":"Mueller PP","year":"2025","unstructured":"Mueller PP, Tajima A, Cassell K, et al. Health and economic impact of the 21-valent pneumococcal conjugat vaccine (V116) for adults in Japan: A delta price approach. J Med Econ. 2025;28(1):136\u2013145.","journal-title":"J Med Econ"},{"key":"e_1_3_7_13_1","unstructured":"Ministry of Health Labor and Welfare. 58th health sciences council on immunisation - basic immunisation policy subcommittee of the subcommittee on vaccines. 2020 [cited 2024 Jan 1]. Available from: https:\/\/www.mhlw.go.jp\/stf\/newpage_36952.html"},{"key":"e_1_3_7_14_1","unstructured":"Ministry of Health Labor and Welfare. Materials from the 58th meeting of the vaccination and vaccine subcommittee basic vaccination policy subcommittee health and science council. 2020 [cited 2025 Aug 14]. Available from: https:\/\/www.mhlw.go.jp\/stf\/newpage_38621.html"},{"key":"e_1_3_7_15_1","unstructured":"MSD K.K. Tokyo Japan. MSD K.K. Tokyo Japan applies for approval of 21-valent pneumococcal conjugate vaccine designed specifically for adults. 2024 [cited 2025 Jan 23]. Available from: https:\/\/www.msd.co.jp\/news\/product-news-20240809\/"},{"key":"e_1_3_7_16_1","unstructured":"Pharmaceuticals and Medical Devices Agency. Label for pneumococcal 21-valent conjugate vaccine. 2025 [cited 2025 Aug 14]. Available from: https:\/\/www.pmda.go.jp\/PmdaSearch\/iyakuDetail\/GeneralList\/631140N"},{"key":"e_1_3_7_17_1","unstructured":"European Medicines Agency. Capvaxive pneumococcal polysaccharide conjugate vaccine (21-valent). 2025 [cited 2025 Jul 17]. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/capvaxive"},{"key":"e_1_3_7_18_1","unstructured":"Government of Canada. Pneumococcal vaccines: Canadian immunization guide. 2024 [cited 2025 Jul 17]. Available from: https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/healthy-living\/canadian-immunization-guide-part-4-active-vaccines\/page-16-pneumococcal-vaccine.html"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2025.2518847"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2024.107024"},{"key":"e_1_3_7_21_1","first-page":"107","article-title":"Pneumococcal infections in 2017, Japan","volume":"39","author":"National Institute for Infectious Diseases","year":"2018","unstructured":"National Institute for Infectious Diseases. Pneumococcal infections in 2017, Japan. Infect Agents Surveillance Report. 2018;39:107\u2013108. https:\/\/id-info.jihs.go.jp\/idsc\/niid\/images\/idsc\/iasr\/39\/461.pdf","journal-title":"Infect Agents Surveillance Report"},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2025.2461814"},{"key":"e_1_3_7_23_1","unstructured":"Ministry of Health Labor and Welfare. Number of people administered routine vaccinations. [cited 2025 Jan 23]. Available from: https:\/\/www.mhlw.go.jp\/topics\/bcg\/other\/5.html"},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.04.062"},{"key":"e_1_3_7_25_1","unstructured":"E-Stat. Population estimates annual report. 2025 [cited 2025 Jun 18]. Available from: https:\/\/www.e-stat.go.jp\/en\/stat-search\/files?page=1&layout=datalist&toukei=00200524&tstat=000000090001&cycle=7&month=0&tclass1=000001011679&cycle_facet=tclass1%3Acycle&tclass2val=0&metadata=1&data=1"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaf689"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.126390"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-018553"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2021.12.365"},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0305892"},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-025-01111-8"},{"key":"e_1_3_7_32_1","unstructured":"Epidemiology of Invasive Pneumococcal Disease in Children and Adults. Adult epidemiological information overview of fiscal years 2013\u20132024. 2025 [cited 2023 Jun]. Available from: https:\/\/ipd-information.com\/adult\/"},{"issue":"1","key":"e_1_3_7_33_1","article-title":"Pneumococcal infections in 2022, Japan","volume":"44","author":"National Institute for Infectious Diseases","year":"2023","unstructured":"National Institute for Infectious Diseases. Pneumococcal infections in 2022, Japan. Infect Agents Surveillance Report. 2023;44(1). https:\/\/id-info.jihs.go.jp\/idsc\/niid\/images\/idsc\/iasr\/44\/515.pdf","journal-title":"Infect Agents Surveillance Report"},{"key":"e_1_3_7_34_1","unstructured":"Epidemiology of Invasive Pneumococcal Disease in Children and Adults. Pediatric epidemiological information overview of fiscal years 2013\u20132024. 2025 [cited 2023 Jun]. Available from: https:\/\/ipd-information.com\/child\/overview\/"},{"key":"e_1_3_7_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-06950-w"},{"key":"e_1_3_7_36_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0122247"},{"key":"e_1_3_7_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chpulm.2023.100007"},{"key":"e_1_3_7_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.07.041"},{"key":"e_1_3_7_39_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1458307"},{"key":"e_1_3_7_40_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268820000813"},{"key":"e_1_3_7_41_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268815001272"},{"key":"e_1_3_7_42_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31828701ea"},{"key":"e_1_3_7_43_1","unstructured":"E-Stat. Number of births percentage and birth rate by year (per 1 000 female population) by mother\u2019s age (5-year age group). 2025 [cited 2025 Jun]. Available from: https:\/\/www.e-stat.go.jp\/dbview?sid=0003411599"},{"key":"e_1_3_7_44_1","unstructured":"E-Stat. Life tables. 2025 [cited 2025 Jun 18]. Available from: https:\/\/www.e-stat.go.jp\/stat-search\/files?page=1&toukei=00450012&tstat=000001031336"},{"key":"e_1_3_7_45_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12976-019-0102-8"},{"key":"e_1_3_7_46_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa035060"},{"key":"e_1_3_7_47_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00325-2015"},{"key":"e_1_3_7_48_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1408544"},{"key":"e_1_3_7_49_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0169368"},{"key":"e_1_3_7_50_1","unstructured":"Ministry of Health Labor and Welfare. Number of people receiving routine vaccinations after the revision of the law in 1994 (transition of implementation rate). 2023 [cited 2025 Aug 14]. Available from: https:\/\/www.mhlw.go.jp\/topics\/bcg\/other\/5.html"},{"key":"e_1_3_7_51_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1690332"},{"key":"e_1_3_7_52_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu213"},{"key":"e_1_3_7_53_1","doi-asserted-by":"publisher","DOI":"10.1017\/S095026881700125X"},{"key":"e_1_3_7_54_1","unstructured":"Wolfram Research. NMinimize Wolfram language function (updated 2024). 2003. Available from: https:\/\/reference.wolfram.com\/language\/ref\/NMinimize.html"},{"key":"e_1_3_7_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2025.06.008"},{"key":"e_1_3_7_56_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2024.2323133"},{"key":"e_1_3_7_57_1","doi-asserted-by":"publisher","DOI":"10.1080\/00401706.1979.10489755"},{"key":"e_1_3_7_58_1","doi-asserted-by":"publisher","DOI":"10.1080\/00401706.1987.10488205"},{"key":"e_1_3_7_59_1","doi-asserted-by":"publisher","DOI":"10.1080\/00224065.1981.11978748"},{"key":"e_1_3_7_60_1","doi-asserted-by":"publisher","DOI":"10.52225\/narra.v4i3.1380"},{"key":"e_1_3_7_61_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis359"},{"key":"e_1_3_7_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.10.010"},{"key":"e_1_3_7_63_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2024.2350246"},{"key":"e_1_3_7_64_1","doi-asserted-by":"publisher","DOI":"10.52225\/narrax.v3i3.230"},{"key":"e_1_3_7_65_1","doi-asserted-by":"publisher","DOI":"10.1080\/20016689.2021.2010956"},{"key":"e_1_3_7_66_1","doi-asserted-by":"publisher","DOI":"10.1093\/pnasnexus\/pgad153"},{"key":"e_1_3_7_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2023.05.065"},{"key":"e_1_3_7_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(24)00161-0"},{"key":"e_1_3_7_69_1","doi-asserted-by":"publisher","DOI":"10.1136\/jech-2015-205777"},{"key":"e_1_3_7_70_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-022-04446-z"},{"key":"e_1_3_7_71_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079578"}],"container-title":["Expert Review of Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14760584.2026.2678266","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T05:11:51Z","timestamp":1779772311000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14760584.2026.2678266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/14760584.2026.2678266"],"URL":"https:\/\/doi.org\/10.1080\/14760584.2026.2678266","relation":{},"ISSN":["1476-0584","1744-8395"],"issn-type":[{"value":"1476-0584","type":"print"},{"value":"1744-8395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-04-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2678266"}}